The North American subsidiary of Amsterdam-based Royal Philips reached an agreement on a consent decree with the U.S. Department of Justice, representing the Food and Drug Administration, the company ...

A number of Philips ($PHG) automated external defibrillators may still be duds, potentially failing to deliver the shock needed in an emergency despite a recall ...

A faulty electronic component in some Philips HeartStart automated external defibrillators may prevent the device from delivering a needed shock to a person suffering a cardiac emergency, the FDA ...

Amsterdam, the Netherlands and Cambridge, MA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the Center for Devices and Radiological Health (CDRH) of ...

The Food and Drug Administration (FDA) is warning consumers that some models of HeartStart automated external defibrillators (AED) may not work during a cardiac emergency. The devices, which are made ...

Royal Philips Electronics (NYSE: PHG, AEX: PHI) is introducing Philips HeartStart FR3 automated external defibrillator (AED) during Arab Health, for professional responders in the region who treat ...

On August 3, 2017, a Boston jury awarded Philips $10.4 million in damages for ZOLL’s infringement of three patents relating to automated external defibrillators. This represents only a fraction of the ...

Royal Philips Electronics, a pioneer in developing treatments to combat sudden cardiac arrest, and Air France-KLM Group, one of the leading European air transport group, today announced an agreement ...